PODD Stock Up on Q4 Earnings & Revenue Beat, Margins Rise

Core Insights - Insulet Corporation (PODD) reported a fourth-quarter 2025 adjusted earnings per share (EPS) of $1.55, reflecting a 34.8% increase year-over-year, surpassing the Zacks Consensus Estimate by 4.87% [1] - Full-year 2025 EPS reached $4.97, a 53.4% increase from the previous year, also exceeding the Zacks Consensus Estimate by 1.2% [1] Revenue Performance - Total revenues for the fourth quarter amounted to $783.8 million, beating the Zacks Consensus Estimate by 2.15% and showing a year-over-year increase of 31.2% [2] - Full-year 2025 revenues were reported at $2.71 billion, a 30.7% increase from the prior year, surpassing the Zacks Consensus Estimate by 0.7% [2] Segmental Revenue Breakdown - Omnipod revenues totaled $781.8 million, up 33.5% year-over-year, with international revenues rising 50.7% [4] - U.S. Omnipod revenues grew 28% year-over-year to $567.8 million, while Drug Delivery business revenues fell 83.4% to $2 million [4] Margin Analysis - Gross profit for the quarter was $568.6 million, a 31.9% increase from the prior year, with a gross margin of 72.5%, expanding by 32 basis points [5] - Operating profit reached $146.3 million, up 33.7% year-over-year, with an operating margin of 18.7%, expanding by 36 basis points [6] Cash Position - Insulet ended the fourth quarter with cash and cash equivalents of $716.1 million, down from $953.4 million at the end of 2024 [7] - Cumulative net cash from operating activities was $569.3 million, compared to $430.2 million in the previous year [7] Future Outlook - For 2026, Insulet projects total revenue growth of 20%-22% at constant exchange rates, with Omnipod revenue growth expected between 21%-23% [9] - The company anticipates a revenue decline of approximately 50% for Drug Delivery in 2026 [9] - For the first quarter of 2026, revenue growth is projected at 25%-27%, with Omnipod revenues expected to rise 28%-30% [10] Overall Performance - Insulet achieved record new Omnipod customer starts in both U.S. and international markets, with significant growth driven by volume and positive price realization [11] - The company marked its tenth consecutive year of revenue growth above 20% at constant currency [12]